Filing Details

Accession Number:
0001209191-17-020949
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-15 20:24:04
Reporting Period:
2017-03-10
Filing Date:
2017-03-15
Accepted Time:
2017-03-15 20:24:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1020214 Cerus Corp CERS Surgical & Medical Instruments & Apparatus (3841) 680262011
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1574700 Carol Moore C/O Cerus Corporation
2550 Stanwell Drive
Concord CA 94520
Svp Reg. & Quality No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-03-10 6,000 $0.00 27,960 No 4 M Direct
Common Stock Disposition 2017-03-14 2,377 $4.15 25,583 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2017-03-10 6,000 $0.00 6,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,000 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one (1) share of Cerus Common Stock.
  2. Includes an aggregate of 18,886 shares purchased under Issuer's Employee Stock Purchase Plan.
  3. Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units listed in Table II. This sale is mandated by the election to satisfy the minimum statutory tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary sale by the reporting person.
  4. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.15 to $4.1457 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
  5. The restricted stock unit vests in three equal annual installments beginning on March 10, 2017.
  6. Not applicable.